About AIA Hong Kong and AIA Macau
AIA Hong Kong and AIA Macau are subsidiaries of AIA Group Limited. AIA Group Limited established its operations in Hong Kong in 1931. We have approximately 12,000 financial planners*, as well as an extensive network of brokerage and bancassurance partners who serve more than 1.8 million customers*. Our products range from individual life, group life, accident, medical and health, personal lines insurance to investment-linked products with numerous investment options. We are also dedicated to providing superb product solutions to meet the financial needs of high net worth customers.
* As of February 2016

About AIA
AIA Group Limited and its subsidiaries (collectively “AIA” or the “Group”) comprise the largest independent publicly listed pan-Asian life insurance group. It has a presence in 18 markets in Asia-Pacific – wholly-owned branches and subsidiaries in Hong Kong, Thailand, Singapore, Malaysia, China, Korea, the Philippines, Australia, Indonesia, Taiwan, Vietnam, New Zealand, Macau, Brunei, a 97 per cent subsidiary in Sri Lanka, a 49 per cent joint venture in India and a representative office in Myanmar and Cambodia.

The business that is now AIA was first established in Shanghai almost a century ago. It is a market leader in the Asia-Pacific region (ex-Japan) based on life insurance premiums and holds leading positions across the majority of its markets. It had total assets of US$168 billion as of 30 November 2015.

AIA meets the long-term savings and protection needs of individuals by offering a range of products and services including life insurance, accident and health insurance and savings plans. The Group also provides employee benefits, credit life and pension services to corporate clients. Through an extensive network of agents, partners and employees across Asia-Pacific, AIA serves the holders of more than 29 million individual policies and over 16 million participating members of group insurance schemes.

AIA Group Limited is listed on the Main Board of The Stock Exchange of Hong Kong Limited under the stock code “1299” with American Depositary Receipts (Level 1) traded on the over-the-counter market (ticker symbol: “AAGIY”).

About Medix Medical Services
Medix is a global company specializing in quality global medical management. With constant scientific development expanding different treatment alternatives and medical technologies, Medix serves as a mediator between its clients and the constantly shifting world of medicine, enabling them to take full advantage of the advances it has to offer. Medix supports is customer base of over 1.5 million people, by leveraging on Medix' 300 in-house specialists, on its global quality accredited network comprised of over 3,000 specialists and 1,500 leading medical centers; Medix provides its patients with access to the best possible care in over 90 countries, 24hours a day, 7 days a week, in over 20 languages, including Cantonese and Mandarin. Medix is also proud to share that over the last years it has provided its global customers with proven better medical outcomes: in 20% of the cases Medix has changed the diagnosis and in 43% of the cases Medix recommended a different and optimal treatment plan and prevented unnecessary medical consultations and procedures in 55% of the cases (yearly averages).

Further, Medix is also involved in supporting government related entities and insurers in developing their healthcare strategies and health care reforms, including implementation of medical governance & clinical quality strategies. Believing that accessibility and sustainability of quality care are one of the most important components in fundamental social rights, Medix is very passionate about these issues and is fully dedicated to these activities. In addition to its activities, Medix engages in Charity and funds various public medical research and clinical programs with the aim to support people in obtaining diagnoses and treatments for rare and complex medical conditions.

Last but not least, with the view that digital health will continue to impact and disrupt the way health care is provided and consumed, the Medix Group has decided to launch a Venture Capital Fund, Medix Ventures, with a strong focus on Asia Pacific, aiming to innovate and capitalize on the opportunities within the digital health space. This will enable disruptive digital health solutions to be embedded into the global Medix medical platform servicing customers globally.